Hepatitis D ultrasound: Difference between revisions
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) |
||
| Line 9: | Line 9: | ||
The following findings may be identified:<ref name=WHO1>{{cite web | title = Hepatitis D | url = http://www.who.int/csr/disease/hepatitis/HepatitisD_whocdscsrncs2001_1.pdf }}</ref> | The following findings may be identified:<ref name=WHO1>{{cite web | title = Hepatitis D | url = http://www.who.int/csr/disease/hepatitis/HepatitisD_whocdscsrncs2001_1.pdf }}</ref> | ||
*Coarse [[echogenicity]] | *Coarse [[echogenicity]] | ||
*Segmental [[hypertrophy]] with nodular appearance of [[liver]] | *Segmental [[hypertrophy]] with nodular appearance of the [[liver]] | ||
*[[Portal hypertension]]: | *[[Portal hypertension]]: | ||
:*[[Splenomegaly]] | :*[[Splenomegaly]] | ||
| Line 19: | Line 19: | ||
[[HBsAg]] carriers should have regular serial [[serum]] [[alpha-fetoprotein]] determinations, and [[ultrasound]] examinations (with 6 month intervals) for those above 40 years of age.<ref name=WHO1>{{cite web | title = Hepatitis B | url = http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index3.html }}</ref> | [[HBsAg]] carriers should have regular serial [[serum]] [[alpha-fetoprotein]] determinations, and [[ultrasound]] examinations (with 6 month intervals) for those above 40 years of age.<ref name=WHO1>{{cite web | title = Hepatitis B | url = http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index3.html }}</ref> | ||
Both these tests are recommended to be repeated regularly for all [[HBsAg]] carriers with [[cirrhosis]].<ref name=WHO1>{{cite web | title = Hepatitis D | url = http://www.who.int/csr/disease/hepatitis/HepatitisD_whocdscsrncs2001_1.pdf }}</ref> | Both these tests are recommended to be repeated regularly, for all [[HBsAg]] carriers with [[cirrhosis]].<ref name=WHO1>{{cite web | title = Hepatitis D | url = http://www.who.int/csr/disease/hepatitis/HepatitisD_whocdscsrncs2001_1.pdf }}</ref> | ||
[[File:HCC ultrasound1.png|thumb|center|250px|Large HCC filling portion of the right lobe]] | [[File:HCC ultrasound1.png|thumb|center|250px|Large HCC filling portion of the right lobe]] | ||
Revision as of 00:28, 4 August 2014
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D ultrasound On the Web |
|
American Roentgen Ray Society Images of Hepatitis D ultrasound |
|
Risk calculators and risk factors for Hepatitis D ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]
Overview
The ultrasound may be used as a screening tool in patients with chronic hepatitis for the early detection of hepatic cirrhosis. Attending to the required concomitant existance of HDV and HBV, HBsAg carriers with cirrhosis should be echographically evaluated every 6 months.
Ultrasound
The following findings may be identified:[1]
- Coarse echogenicity
- Segmental hypertrophy with nodular appearance of the liver
- Portal hypertension:
HBsAg carriers should have regular serial serum alpha-fetoprotein determinations, and ultrasound examinations (with 6 month intervals) for those above 40 years of age.[1]
Both these tests are recommended to be repeated regularly, for all HBsAg carriers with cirrhosis.[1]
References
- ↑ 1.0 1.1 1.2 "Hepatitis D" (PDF).